| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,702,938 | 3,080,425 | 3,194,669 | 3,102,559 | | Cost of Revenue | 1,944,251 | 2,294,785 | 2,462,949 | 2,363,239 | | | Gross Profit | 758,687 | 785,640 | 731,720 | 739,320 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 555,705 | 590,871 | 589,179 | 575,236 | | Non Recurring | 8,248 | 6,388 | 8,960 | 5,195 | | Others | 1,908 | 4,787 | 1,767 | 1,711 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 192,826 | 183,594 | 131,814 | 157,178 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (195) | (418) | 242 | (138) | | Earnings Before Interest And Taxes | 192,631 | 183,176 | 132,056 | 157,040 | | Interest Expense | 68,299 | 73,054 | 74,709 | 76,485 | | Income Before Tax | 124,332 | 110,122 | 57,347 | 80,555 | | Income Tax Expense | 48,990 | 42,742 | 19,544 | 31,670 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 75,342 | 67,380 | 37,803 | 48,885 | | | Non-recurring Events | | Discontinued Operations | (142) | (1,019) | (51) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 75,200 | 66,361 | 37,752 | 48,885 | | Preferred Stock And Other Adjustments | 1,046 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $76,246 | $66,361 | $37,752 | $48,885 |
|
0.45% Nasdaq 
0.20%
Income Statement
